ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000800.1|Xanthan_1 # 33 # 332 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.600	BGC0000800.1|Xanthan_1 	33	332	+	Loose	500	28.4906	sul4	33.33	3004361	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGGCATTGACGAAAGCGGAGATGGCCGAGCGTCTGTTCGACGAAGTCGGCCTGAACAAGCGTGAGGCGAAGGAATTCGTCGACGCGTTTTTCGATGTGCTGCGCGATGCACTGGAGCAGGGCCGTCAGGTGAAGTTGTCGGGCTTCGGCAACTTCGATCTGCGGCGCAAGAACCAACGGCCCGGTCGCAATCCCAAGACCGGTGAGGAAATTCCGATCTCGGCCAGGACGGTGGTGACCTTCCGCCCCGGCCAGAAACTCAAGGAACGGGTGGAGGCTTATGCTGGATCCGGGCAGTAA	MALTKAEMAERLFDEVGLNKREAKEFVDAFFDVLRDALEQGRQVKLSGFGNFDLRRKNQRPGRNPKTGEEIPISARTVVTFRPGQKLKERVEAYAGSGQ	MSTTLTSFKWGERTYIMGILNVTPDSFSGDGVMVEEDVIAKAVAQAKQFVADGADIIDIGGESTRPGSSPISAEEELARVLPVVQAVRQAVDVVISIDSYRASVAEAALAAGASWLNDVWGLRMDPDMAGLAAQAGCPIVLMHNRSKPKNIAQEKKLGGRFIGVKYDDLITDVKRELQESIDIALKAGVKESQIILDPGIGFGKTVEQSLQLLDQINQFKTMGFPILIGPSRKSFIGYTLDLPPDQRIEGTAATVAIGIDRGADVVRVHDVKAIVRVARMTDAIVRR	34.49	gnl|BL_ORD_ID|2483|hsp_num:0	2875			108	225	sulfamethoxazole
BGC0000800.1|Xanthan_2 # 313 # 669 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.616	BGC0000800.1|Xanthan_2 	313	669	+	Loose	275	25.0238	AAC(6')-IIb	42.31	3002595	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGCTGGATCCGGGCAGTAATCGCGAGCTACCGCCGATTCCGGCCAAGCGCTACTTCACCATCGGTGAGGTGAGCGAGCTGTGCGACGTCAAGCCGCACGTGCTGCGCTATTGGGAAACCGAATTTCCGAGCCTGGAGGCCAGTCAAGCGGCGCGCAACCGACGCTACTACCAGCGGCACGATGTCGTGATGGTGCGGCAGATTCGTGGCCTGCTGTACGAGCAGGGTTACACCATCGGGGGCGCGCGTCTGCGTCTTGAAGGGGATGGGGCCAAGAGCGAGTCAGCGCTGAGCAATCAGATCATCAAGCAGGTGCGCATGGAGCTTGAAGAAGTCCTGCAGCTGCTGCGACGCTAG	MLDPGSNRELPPIPAKRYFTIGEVSELCDVKPHVLRYWETEFPSLEASQAARNRRYYQRHDVVMVRQIRGLLYEQGYTIGGARLRLEGDGAKSESALSNQIIKQVRMELEEVLQLLRR	MHPGVVTLRPMTEDDIGMLHEWLNRPHIVEWWGGERPSLEEVKEDYRPSALAEEGVTPYIGLLDGTPFAFAQSYVALGSGGGWWEEETDPGVRGIDQSIADSGLLGRGYGTRLVQALVDLLFADPQVSKVQTDPSPNNMRAIRCYEKAGFRKVKVVSTPDGPAMYMLHERPLVNGLRSAA	65.56	gnl|BL_ORD_ID|121|hsp_num:0	140			45	120	dibekacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin; gentamicin
BGC0000800.1|Xanthan_3 # 1403 # 1975 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.616	BGC0000800.1|Xanthan_3 	1403	1975	+	Loose	650	24.6386	mexM	35.14	3003704	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCCACGGTGCAGCCCGAATACCGTCTTGCGCCGGGCGATCTGTTGCTGGTGAAGGTGTTTCAGATCGACGATCTGGAGCGGCAGGTCCGCATCGACCAGAACGGTCACATCTCACTGCCGTTGATTGGCGACGTCAAGGCCGCCGGTCTGGGCGTTGGCGAACTGGAAAAGCTGGTCGCCGATCGGTATCGCGCAGGCTACCTGCAGCAGCCGCAGATTTCGGTATTCGTGCAGGAGTCCAACGGGCGTCGCGTCACGGTCACTGGTGCGGTAGACGAGCCGGGCATCTACCCGGTGATCGGCGCCAACCTCACCTTGCAGCAGGCGATCGCGCAGGCCAAGGGTGTCAGCACGGTGGCAAGCCGCGGCAACGTGATCGTGTTCCGCATGGTCAACGGGCAAAAAATGATTGCGCGGTTCGACCTGACCGAGATCGAGAAGGGGGCCAATCCGGATCCTGAGATTTATGGCGGCGACATTGTCGTGGTGTATCGCTCGGATGCGCGCGTGTGGTTGCGCACCATGCTGGAACTGACCCCCTTGGTGATGGTGTGGCGCGCTTACCGATGA	MSTVQPEYRLAPGDLLLVKVFQIDDLERQVRIDQNGHISLPLIGDVKAAGLGVGELEKLVADRYRAGYLQQPQISVFVQESNGRRVTVTGAVDEPGIYPVIGANLTLQQAIAQAKGVSTVASRGNVIVFRMVNGQKMIARFDLTEIEKGANPDPEIYGGDIVVVYRSDARVWLRTMLELTPLVMVWRAYR	MQALRSGGGRVLVGVLAAGLVAFGGWAWLGGDAGAKAAPAPARVPVIVARVERRDVEQQVSGIGTVTSLHNVVIRTQIDGQLTRLLVSEGQMVEAGELLATIDDRAVVAALEQAQASRASNQAQLKSAEQDLQRYRSLYAERAVSRQLLDQQQATVDQLRATLKANDATINAERVRLSYTRITSPVSGKVGIRNVDVGNLVRVGDSLGLFSVTQIAPISVVFSLQQEQLLQLQALLGGEAAVRAYSRDGGSALGEGRLLTIDNQIDSSTGTIRVRASFDNRQARLWPGQFVAVSLHTGVRRDQLVLSSKAVRRGLEGNFVYRVADDRVEAVPVRVLQDIDGLSVVEGLASGDQVVVDGHSRLMPGALVDIQEPRPSLAQATERRP	49.35	gnl|BL_ORD_ID|2020|hsp_num:0	2216			132	243	chloramphenicol; thiamphenicol
BGC0000800.1|Xanthan_4 # 2048 # 3397 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.606	BGC0000800.1|Xanthan_4 	2048	3397	+	Loose	700	28.8758	CMY-163	27.96	3005193	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGGACTACTGGCGCGCCCTGGTCTCGCAGCTCTGGCTGATCATCCTGATCGCCGTCGGCGCGCTGTTGCTGGCATTCGGCATCACGATGTTGATGCCCGAGAAGTACCGCGCCACCAGCACCCTGCAGATCGAACGTGACTCGCTCAATGTGGTGAACGTCGACAACCTGATGCCGGTGGAATCGCCGCAGGATCGCGATTTCTACCAGACCCAGTACCAGTTGCTGCAGAGCCGTTCGCTGGCGCGTGCGGTGATCCGGGAAGCCAAGCTCGATCAGGAGCCGGCGTTCAAGGAGCAGGTGGAGGAGGCGCTGGCCAAAGCCGCCGAAAAGAATCCCGAGGCGGGTAAGTCGCTCGATTCGCGGCAGGCGATCGTCGAGCGCAGCCTCACCGATACGTTGCTCGCCGGGCTGGTGGTCGAGCCGATCCTCAACTCGCGCCTGGTGTACGTCAATTACGATTCGCCAGACCCGGTGCTGGCCGCCAAGATCGCCAATACGTACCCGAAGGTGTTCATCGTCAGCACCCAGGAACGCCGCATGAAGGCGTCTTCGTTTGCGACACAGTTTCTGGCTGAGCGCCTGAAGCAGTTGCGCGAGAAGGTCGAAGACTCTGAAAAGGATCTGGTCTCGTATTCGACCGAAGAGCAGATCGTGTCGGTTGGCGATGACAAGCCCTCGCTGCCTGCGCAGAATCTGACCGATCTCAATGCGTTGCTGGCATCCGCACAGGACGCCCGGATCAAGGCCGAGTCAGCTTGGCGGCAGGCTTCCAGTGGCGATGGCATGTCATTGCCGCAGGTGTTGAGCAGCCCGCTGATTCAAAGCCTGCGCAGCGAGCAGGTGCGTCTGACCAGCGAGTACCAGCAGAAACTGTCGACCTTCAAGCCGGATTACCCGGAGATGCAGCGCCTCAAGGCGCAGATCGAAGAGTCGCGTCGTCAGATCAATGGCGAAGTCATCAATATCCGTCAGTCGCTGAAGGCGACCTACGACGCCTCCGTGCATCAGGAGCAGCTGCTCAACGACCGCATCGCCGGTCTGCGGTCCAACGAGCTGGATCTGCAGAGCCGCAGCATCCGCTACAACATGCTCAAGCGCGACGTCGACACCAACCGCCAGCTCTACGATGCGCTCCTGCAGCGCTACAAGGAAATCGGCGTGGCGAGCAACGTGGGCGCCAACAACGTGACCATCGTCGATACCGCAGACGTGCCTACGTCTAAGACTTCGCCGAAACTCAAATTGAACCTCGCGTTGGGCCTGATCTTTGGCGTATTCCTGGGCGTGGCTGTGGCTCTGGTTCGCTACTTCCTGCGTGGGCCTTCTCCGAGGTCGCGGTTGAACTGA	MDYWRALVSQLWLIILIAVGALLLAFGITMLMPEKYRATSTLQIERDSLNVVNVDNLMPVESPQDRDFYQTQYQLLQSRSLARAVIREAKLDQEPAFKEQVEEALAKAAEKNPEAGKSLDSRQAIVERSLTDTLLAGLVVEPILNSRLVYVNYDSPDPVLAAKIANTYPKVFIVSTQERRMKASSFATQFLAERLKQLREKVEDSEKDLVSYSTEEQIVSVGDDKPSLPAQNLTDLNALLASAQDARIKAESAWRQASSGDGMSLPQVLSSPLIQSLRSEQVRLTSEYQQKLSTFKPDYPEMQRLKAQIEESRRQINGEVINIRQSLKATYDASVHQEQLLNDRIAGLRSNELDLQSRSIRYNMLKRDVDTNRQLYDALLQRYKEIGVASNVGANNVTIVDTADVPTSKTSPKLKLNLALGLIFGVFLGVAVALVRYFLRGPSPRSRLN	MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLTHTWITVPQNEQKDYAWGYREGKPVHSSPRQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	117.85	gnl|BL_ORD_ID|2890|hsp_num:0	3909			558	819	
BGC0000800.1|Xanthan_6 # 5177 # 6475 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.574	BGC0000800.1|Xanthan_6 	5177	6475	+	Loose	50	27.7202	vanW gene in vanG cluster	23.08	3002965	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanW; glycopeptide resistance gene cluster	ATGCTGATTCAAATGAGCGAGCAGGCGCGGGTGCGTTGGCACAACGCGCTGATCGAGCTGACCCTGCTGACCGGCGTGGGCTACAACCTGCTGCTGGCGTTGATCAACGCCAACGTGTTCACCGTACGTCCGGTGATCACATATGCAGTGGAATTTCTGGTCTACGCAGCCTGTTTCCTGCTCGGGCTGGGCTCGATGAGCCGACAGCGCATCGCGATGATCTTCGGCGGGCTAGGCTTGATCGTGACGCTGATGTTCGTGCGTTTCCTGGTCAACTGGCAGATCGACCCCAAGTTCTTCCGCGATGCCCTGGTGGTCTTTGCATTTGTCGTGCTGGGGTCTGCTTACACCGGCTCGTTGCCCAAGCTGTTCATACGCATGACGATCATCGTGTCATTGGTCGCTGCGTTCGAGCTGGCGATGCCCTCGGCTTATGGCGATCTGGTCAACCCGAAGAGCTTCTTCGTCAATGCGCGCGGCATGAGTGCAGAAGGGTTCTGGAACGAGGACAGCAATCTGTTCGTCAGTGCCACACGACCCGGTGAGCGCAACTTCCTCCCAGGCTCGAACCTGCCACGCGCCTCTTCCTGGTTCATCGAGCCGGTGACGATGGGCAATTACATCTGCTTCTTCACCGCGATCGTATTGACGTTCTGGCGCTGGATGCGGCCGTCGATGCTGATTCTGTCTATTGGATTGATCGGCTTCATGATTGTGGCATCCGACGGCCGACTGGCTGCCGGCACCTGTGTGCTGATGGTGCTGCTGTCGCCGTTATTGAAACGGATGGATCAGCGGTTGGCGTTCCTGTTGTTCCTGTTTGTGATCGCCTCTGCCTGGCTGCTGGTGTGGATGACCGGGATTACGGCCTACCAGGACACCACGATGGGGCGCATCTTCTTCACTGTGAATTCGATGAACAATCTATCGTTCGAGTCGTGGATGGGCCTGGATTTTGCGCAGGCCTACCGGTATTTCGACAGCGGTATTTCTTACTTTATTGCTTCGCAGTCGATTGTCGGCGTGCTGGCGTTCCTGCTGTCTTATTCGTTCCTGCTGCTGATGCCGAGCAAGGAAGGGCAGTTGTTCAAAAACCAGGCGATGTTTGCCTTTGCACTGAGCCTGTTGGTGTCTAACGGCTATTTCTCGATCAAGACATCGGCGCTGTGGTGGTTTGTCTGCGGCTGCATGTGGCACCTGATGCCAGCAGCGTCAGCCGTGCCGGTGCGCGACGAAAGCAAGGAAGATCCAACGGACAACGGCGTGCATGTGCCGTTGCCCGCAGGAGCGCCGCGGTGA	MLIQMSEQARVRWHNALIELTLLTGVGYNLLLALINANVFTVRPVITYAVEFLVYAACFLLGLGSMSRQRIAMIFGGLGLIVTLMFVRFLVNWQIDPKFFRDALVVFAFVVLGSAYTGSLPKLFIRMTIIVSLVAAFELAMPSAYGDLVNPKSFFVNARGMSAEGFWNEDSNLFVSATRPGERNFLPGSNLPRASSWFIEPVTMGNYICFFTAIVLTFWRWMRPSMLILSIGLIGFMIVASDGRLAAGTCVLMVLLSPLLKRMDQRLAFLLFLFVIASAWLLVWMTGITAYQDTTMGRIFFTVNSMNNLSFESWMGLDFAQAYRYFDSGISYFIASQSIVGVLAFLLSYSFLLLMPSKEGQLFKNQAMFAFALSLLVSNGYFSIKTSALWWFVCGCMWHLMPAASAVPVRDESKEDPTDNGVHVPLPAGAPR	MIEVYKLTQRKRLTQLFPFLLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETSSLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKLRNDTDNTFQIEISFDDNFMYGRILSQSSVNIEYTVFNSSVSYFKREEKVYQIASVCRTEKDKMTGSQTEKELYVNQCEIAYKLPDDVKIEERGV	153.74	gnl|BL_ORD_ID|4741|hsp_num:0	1622			654	810	vancomycin
BGC0000800.1|Xanthan_7 # 6472 # 7566 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.613	BGC0000800.1|Xanthan_7 	6472	7566	+	Loose	200	30.4166	vanT gene in vanC cluster	30.0	3002970	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	GTGAATACGGTGACAGGGGCATCGGGGACGTCGGCGCCTGTGCAGGCTGCCGGCGCGCGTGCCTTCGCGAGCGGCCGTAGCCGCGATCCACGTATCGATGCGACCAAGGCGATCGCGATATTGCTGGTGGTGTTCTGCCACGCAAAAGGCGTGCCGCACGGAATGACCCTGTTTGCCTACAGCTTTCACGTTCCGCTTTTCTTCCTCGTGTCGGGTTGGCTGGCTGCCGGTTATGCCTCGCGCACAACCAGCCTGCTGCAGACAATCACCAAGCAGGCACGTGGTCTGTTGCTGCCCTATGTCGTGTTCTATCTGCTTGGATATGTGTATTGGCTGTTGACGCGCAACATCGGCGAGAAAGCTGCACGTTGGGGGAGCCACCCGTGGTGGGAGCCGATCGTGTCGATGTTTACCGGCGTCGGCCCGGATCTGTATGTGCAGCCGCCGCTGTGGTTCCTGCCGGTGATGCTGGTCACCGTGATTGGCTACGTTCTGTTGCGGCGCTGGATGCCGCCACTGGTCATTGCGGCTGTCGCAGTTGTTCTCGCCTGGTTCTGGATGAACTGGTTTCCGCTCCAGCACATGCGATTGTTCTGGGGCCTGGATGTGCTACCGGTGTCGCTGTGCTTCTACGCACTGGGCGCGCTGCTGATCCACGTGTCGCCGTATCTTCCAACCTCCTTGCCTGGTAGCGCGTTGGTCACCGTAGTGCTGGCAGCATTGGTTGCCTGGCTGGCCGGGGTCAACGGCCGCATCGATGTCAACATGCTGGAATTCGGAAGGCAGCATGCCGTATTCCTGTTGAGTGCAGTGGCGGGTTCGTTGATGGTGATCTGCGCGGCGCGCATGGTGCAGGAATGGACATGGCTGCAGTGGATCGGGCGCAACACCTTGCTGATCCTGTGCACGCACATGCTGGTCTTCTTTGTACTGTCTGGTGTTGCGGCCTTGGCGGGTGGGTTTGGTGGGGCGCGCCCAGGCCTTGGTTGGGCCATCTTCGTGACGCTCTTTGCGCTGGTCGCCAGCGTTCCGCTGCGCTGGTTTCTGATGCGTTTTGCCCCCTGGACCTTGGGTGCACGTCCGGTGTCGGCATGA	MNTVTGASGTSAPVQAAGARAFASGRSRDPRIDATKAIAILLVVFCHAKGVPHGMTLFAYSFHVPLFFLVSGWLAAGYASRTTSLLQTITKQARGLLLPYVVFYLLGYVYWLLTRNIGEKAARWGSHPWWEPIVSMFTGVGPDLYVQPPLWFLPVMLVTVIGYVLLRRWMPPLVIAAVAVVLAWFWMNWFPLQHMRLFWGLDVLPVSLCFYALGALLIHVSPYLPTSLPGSALVTVVLAALVAWLAGVNGRIDVNMLEFGRQHAVFLLSAVAGSLMVICAARMVQEWTWLQWIGRNTLLILCTHMLVFFVLSGVAALAGGFGGARPGLGWAIFVTLFALVASVPLRWFLMRFAPWTLGARPVSA	MKNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDILITLTIFRVAVPFFFMISGYYVFAELAVANSYPSRQRVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQVLLVNGILYHLWYFPALITGSLLLTSLLIHVSFKKVFWLAAGLYLIGLGGDSWFGLIQQTPIEPFYTAVFHLLDGTRNGIFFTPLFLCLGVLVRKQSEKRSLSKTALFFLISLIGLLIESAYLHGFSIPKHDSMYLFLPVVLFFLFPLILRWHPHRTWKHPGQLSLWLYLLHPYTIAGTHFLSQKISILQNNLINYLVVLILTIGFICLFLRQKHSWFRHKQTTPVKRAVKEFSKTALLHNLQEIQRIISPKTKVMAVVKADAYGCGAKEVAPVLEQAGIDFFAVATIDEGIRLRKNAVKSPILVLGYTSPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTIDSILSIFDLPFLTISGVYSHLGSADRLNPDSMIRTQKQIACFDQILLELDQRQISYGITHLQSSYGILNYPDLNYDYVRPGILLTGSLSDTNEPTKQRVSLQPILTLKAQLITKRVVAKGEAIGYGQTAVANQETTVGVVSIGYCDGLPRSLSNQEFCLSYRGQSLPQIGLICMDMLLIDLSHCPTIPIESEIEILTDWSDTAEQVQTITNELICRIGPRVSARIK	52.15	gnl|BL_ORD_ID|4675|hsp_num:0	734			3	270	vancomycin
BGC0000800.1|Xanthan_8 # 7563 # 8702 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.603	BGC0000800.1|Xanthan_8 	7563	8702	+	Loose	175	28.4906	vanT gene in vanG cluster	39.29	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGACGACGGCTGCGATCACTGCCGGTCGCGTCGACACAATCGCCTCAACTGTCGCGGAGCGCGACTGGCAGATCGACGTGGCCAAGGCTCTTGCGATCATTCTGGTCGCGCTGGGGCACGCCAGTGGCATGCCGCCTGCCTACAAGCTGTTTGCCTACAGCTTCCATGTGCCTCTGTTTTTCGTTCTTTCCGGCTGGGTCGGTGAACGCTTCGGGCGTCGTGCATTTGGCCGGAAGACGGTGGGAAAGCTTGCGCGCACGCTGCTGATTCCCTACGTCAGCTTTTTTCTGGTGGCTTACGGCTACTGGATACTGAGCGCAGTGCTCAACGGCACATCCCAGTCCTGGGCTGGCCACCCCTGGTGGCATCCGTTTGTTGGATTGCTGTGGGCCAATGGATCCAGCTTGTATGTGCTCCCGGCCTTGTGGTTTCTCCCCGCACTGTTTGTCGCCACCGTTGTCTACCTGGCACTGCGCGAAGACCTGAGCGCCGCAGTGCTCGCGGTCTGCAGTTTGCTGGTTGTGTGGGCGTGGACGCGTTGGTTCCCAGGGCTGCGGCTGCGCCTTCCGTTTGCACTGGATGTGCTGCCGGTCGCGCTGTTCTTCATTGCAGTCGGCGCATGGCTGTCACGCTTCGCAGAGAGAGTGCGCGCGCTTCCTGCGGTCGTTTGGGTCGTCGCGTTCCCGGTCCTGGCATTCGCCTGGGGGGGCGTTGCAGCCATGAACGGGCAGGTGGATGTCAATAATCTTCAGTTCGGAAAATCGTCGCTCCTGTTCCTGATCGCAAGCCTGCTGGGTACAGCAATGACGTTGTGCATTGCCTACTTCATGCAAGGGTGGCGCTGGCTGCGTTGGATCGGCGCCAATACGCTGCTGATCCTTGGCACGCACACGTTGGTGTTTCTGGTCGTGACCAGTGTCGTGGTGCGAACCGGGGTGATCGATCGCAAACTCATCGGTACACCTGTCTGGGCGCTGGCTCTCTGCGCCTTTGCCATCGCTGCCTGCATTCCCATGCGTGCCGTGCTGGTGCGCCGCGCCCTGGATGTTGGGATTGAAACGCAAGTGAGACATTTTCAGAATCATCAGTCGATGTGGCGTGTTCGTGTGAGTCACCGGCAAAGGAGATCGGCGCAATGA	MTTAAITAGRVDTIASTVAERDWQIDVAKALAIILVALGHASGMPPAYKLFAYSFHVPLFFVLSGWVGERFGRRAFGRKTVGKLARTLLIPYVSFFLVAYGYWILSAVLNGTSQSWAGHPWWHPFVGLLWANGSSLYVLPALWFLPALFVATVVYLALREDLSAAVLAVCSLLVVWAWTRWFPGLRLRLPFALDVLPVALFFIAVGAWLSRFAERVRALPAVVWVVAFPVLAFAWGGVAAMNGQVDVNNLQFGKSSLLFLIASLLGTAMTLCIAYFMQGWRWLRWIGANTLLILGTHTLVFLVVTSVVVRTGVIDRKLIGTPVWALALCAFAIAACIPMRAVLVRRALDVGIETQVRHFQNHQSMWRVRVSHRQRRSAQ	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	53.23	gnl|BL_ORD_ID|1522|hsp_num:0	1561			573	657	vancomycin
BGC0000800.1|Xanthan_9 # 8699 # 9841 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.619	BGC0000800.1|Xanthan_9 	8699	9841	+	Loose	525	30.0314	CRP-1	30.14	3006868	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CRP beta-lactamase	ATGAAAGTCGTGCATGTGGTCCGCCAGTTCCATCCGTCGATCGGGGGGATGGAGGAAGTCGTGCTGAACGTGGCACGTCAGCATCAGGCCAACAGTGCCGACACGGTTGAGATCGTGACGTTGGATCGTGTGTTCACCGATCCCTCTGCGCAACTGGCGCAGCACGAGCTCCATCAGGGGTTGTCGATCACTCGCATCGGCTATCGTGGTTCATCGCGGTACCCGATCGCGCCGTCGGTGCTGGGGGCGATCCGTTCGGCGGACGTGGTGCATCTGCATGGCATTGATTTTTTCTACGACTACCTGGCGTTGACCAAGCCGCTGCACGGCAAGCCGATGGTGGTCTCGACGCATGGCGGGTTTTTCCACACTGCCTATGCGTCGCGCATGAAGCAGATCTGGTTCCAGACGCTGACGCGTACTTCTGCGCTGGCCTATGCGCGTGTGATCGCCACTAGCGAGAATGACGGCGATCTGTTCGCCAAGGTGGTCGCGCCGTCGCGCTTGCGGGTGATCGAGAACGGTGTCGACGTGGAGAAGTATGCAGGGCAGGGCGCTCGAGCGCCGGGACGGACCATGCTGTATTTCGGGCGTTGGTCGGTCAACAAGGGCCTGATCGAAACGCTTGAATTGCTGCAGGCTGCGCTCACGCGTGATCCGCAGTGGCGGTTGATCATCGCCGGGCGCGAGTACGATTTGAATGAGGCGGATCTGCGCAAGGCCATCGCCGAACGCGGTTTGCAGGACAAGGTGCAGCTGAGCATGTCGCCATCGCAGCAGCAGTTGTGCGCGTTGATGCAGCAGGCGCAGTTCTTCGTGTGCCTGTCGCGGCATGAGGGGTTTGGGATTGCGGCGGTGGAAGCGATGAGCGCGGGGTTGATCCCGATTCTCAGCGACATTCCTCCGTTCGTGCGGCTTGCCACCGAGTCCGGACAGGGTGTGATCGTCAATCGCGACAGGATTCAGGCCGCGGCCGACAGCGTGCAAGCATTGGCGCTGCAGGCCAATGCGGATTTCGATGCGCGCCGCACGGCGACCATGGCGTATGTGGCGCGCTACGACTGGCGGCACGTGGTGGGGCGTTATATCGACGAGTACCACGCTGCGCTGGGAACACCACGTACGCAGGAGGCCGTGCGATGA	MKVVHVVRQFHPSIGGMEEVVLNVARQHQANSADTVEIVTLDRVFTDPSAQLAQHELHQGLSITRIGYRGSSRYPIAPSVLGAIRSADVVHLHGIDFFYDYLALTKPLHGKPMVVSTHGGFFHTAYASRMKQIWFQTLTRTSALAYARVIATSENDGDLFAKVVAPSRLRVIENGVDVEKYAGQGARAPGRTMLYFGRWSVNKGLIETLELLQAALTRDPQWRLIIAGREYDLNEADLRKAIAERGLQDKVQLSMSPSQQQLCALMQQAQFFVCLSRHEGFGIAAVEAMSAGLIPILSDIPPFVRLATESGQGVIVNRDRIQAAADSVQALALQANADFDARRTATMAYVARYDWRHVVGRYIDEYHAALGTPRTQEAVR	MRLSRRLVLLSCLLLPQAGFSAAMPANLADQKIARLERVFGGQIGVYALDTGSGAAVSYRADERFPLCSSFKGFLAASALAHSQSKPGFLDQILHYGKEELIAWSPISEKHQSSGMTVAGLCAATVQYSDNAAANVLMKQLDGPAGLTAFMRAIGDSTFRLDRWEPELNTAIPGDARDTSTPRAVAESLQKLTLGTALAAHQRQQLVDWLKGNTTGNQRIRAAVPAGWLVGDKTGTCGVYGTANDYAVIWPTGRAPIVMAVYTRASKKDIKHSDAVIADAAKAALEALGVMTR	129.69	gnl|BL_ORD_ID|3415|hsp_num:0	4484			75	279	
BGC0000800.1|Xanthan_10 # 9838 # 10887 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.651	BGC0000800.1|Xanthan_10 	9838	10887	+	Loose	600	26.5646	clbB	42.86	3002815	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGAGCGCGTCTGCTTCGCTGCCAGTGACGCGTGCTGCTGCGGCGCCCCGGATCACGGTGCTGTTCTCCACCGAAAAGCCGAACGCCAACACCAACCCGTATCTCACCCAGCTCTACGATGCGCTGCCGGACGCGGTGCAGCCGCGCTTCTTTTCGATGCGCGAGGCGTTGTTGTCGCGCTACGACGTGCTGCATCTGCACTGGCCGGAATATCTGCTGCGCCATCCCAGCAAGATGGGCACGCTGGCCAAGCAGGCCTGCGCTGCCTTGCTGCTGATGAAGTTGCAGCTGACCGGCACGCCGGTGGTACGCACCTTGCACAACCTGGCGCCGCATGAAGACCGCGGCTGGCGGGAGCGCGCGCTGCTGCGCTGGATCGATCAGCTCACGCGGCGCTGGATCCGCATCAACGCCACTACACCGGTGCGGCCGCCGTTCACCGACACCATCCTGCACGGCCATTACCGCGACTGGTTCGCGACGATGGAGCAGAGCACCACGTTGCCTGGTCGGCTGCTGCATTTTGGATTGATCCGGCCGTACAAGGGCGTTGAGGTGTTGCTCGACGTCATGCGCGGATGTGCAGGACCCGCGCCTGAGCCTGCGCATCGTCGGCAACCCGGCGACGCCAGGATGCGCACGCTGGTCGAAACCGCCTGCGCGCAGGATGCACGTATCAGTGCACTGCTGGCCTATGTCGAGGAGCCGGTGCTCGCGCGCGAAGTCAGTGCCTGCGAACTGGTGGTACTGCCATACAAGCAGATGCACAACTCCGGCACCTTGCTGCTGGCGTTGTCGTTGGCGCGGCCCGTGCTTGCGCCGTGGAGCGAATCGAACGCCGCGATCGCCGACGAAGTCGGGCCGGGTTGGGTGTTCCTGTACGAAGGCGAGTTCGATGCGGCGTTGTTGAGCGGCATGCTCGATCAGGTGCGCGCCGCGCCGCGTGGCCCGGCGCCCGATCTTTCACAACGTGATTGGCCACGGATCGGGCAATTGCACTATCGCACCTACTTGGAAGCGCTCGGCAAGGATGGAGACGCCGCGCTGTGA	MSASASLPVTRAAAAPRITVLFSTEKPNANTNPYLTQLYDALPDAVQPRFFSMREALLSRYDVLHLHWPEYLLRHPSKMGTLAKQACAALLLMKLQLTGTPVVRTLHNLAPHEDRGWRERALLRWIDQLTRRWIRINATTPVRPPFTDTILHGHYRDWFATMEQSTTLPGRLLHFGLIRPYKGVEVLLDVMRGCAGPAPEPAHRRQPGDARMRTLVETACAQDARISALLAYVEEPVLAREVSACELVVLPYKQMHNSGTLLLALSLARPVLAPWSESNAAIADEVGPGWVFLYEGEFDAALLSGMLDQVRAAPRGPAPDLSQRDWPRIGQLHYRTYLEALGKDGDAAL	MKLTSKYETIRRILSECKQPEYRYAQIMDAIFKQNIGEYERMTILPKFLRDELNRILGPNVCSIAPVKELTSKQVSKVLFAIPGDEQVEAVRLTYERGWKSYCISTQCGCGFRCKFCATGTIGLKRNLTADEITDQLLYFRLNGHSLDSISFMGMGEALANPHIFEAMTILTDPYLFGLGHRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLIALDRHIRETGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGAWEHLYHVNLIPFNSTEVTPDSYRQSDPSRIKAFVRILKSRGISVTVRTQFGSDINAACGQLYRSE	101.75	gnl|BL_ORD_ID|109|hsp_num:0	127			567	651	lincomycin; clindamycin; azidamfenicol; chloramphenicol; thiamphenicol; virginiamycin M1; tiamulin; madumycin II; griseoviridin; dalfopristin
BGC0000800.1|Xanthan_11 # 10884 # 12380 # 1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.633	BGC0000800.1|Xanthan_11 	10884	12380	+	Loose	500	25.7942	fexA	24.0	3002704	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGACCGCAGAGACATCGACCATGACTTCCCCAACACCGCCGCCGCGCAGCCTCGGGTCGCGTGCCGCTGGCGCCGCCGTGACCATGATCGGGCAGTCGGCCAAGATGATCGTGCAGTTCGGCGGCATCGTGCTGCTGGCACGCTTGTTGACGCCGTACGACTACGGCTTGATGGCCATGGTGACCGCCATCGTGGGGGCCGCCGAAATCCTGCGCGACTTCGGTCTCTCCGCAGCCGCCGTCCAGGCGAAACATGTCAGCCGCGAGCAACGCGACAACCTGTTCTGGATCAATAGCGGCATCGGTCTGATGCTGTCGGTGGTGGTGTTCGCCAGCGCGCACTGGATTGCGGACTTTTATCACGAGCCCGCATTGGTGACGATTTCGCAGGCATTGGCGGTGACCTTCCTGCTCAACGGGATGACCACCCAATACCGCGCACACCTCAGTCGGGGGCTGCGCTTCGGTCAGGTAGCGCTGAGCGATGTGGGTTCGCAGGTGTTGGGGTTGGGTGCTGCAGTTGCGGCCGCCTTGGCCGGCTGGGGCTACTGGGCGTTGATCGTGCAGCAGGTGGTGCAGGCCATCGTGAACCTGATTATCGCTGGCGCATGTGCACGCTGGTTGCCGCGCGGGTACGCGCGGCAGGCGCCGATGCGCGATTTCATGAGCTTTGGCTGGAACCTGATGGCGGCGCAGCTGCTCGGCTATGCGAGCCGCAACGTTGGCCAGGTGATCATCGGCTGGAGGACCGGGCCCGACGCGCTGGGTCTGTACAACCGTGCCTTCCAGTTGTTGATGATGCCGTTGAATCAGATCAATGCGCCTGCGACTAGTGTGGCGCTGCCGGTGTTGTCGCAATTGCAGGATGAGCGCGAGCGCTACAGCGCTTTTCTGTTGCGCGGCCAGACGGTCATGGTGCATTTGATCTTTGCGCTGTTCGCGTTTGCCTGTGCACTGGCCATGCCGCTCATCGTCCTGGTGCTGGGTGAGCAGTGGCGGGAAGCGGTGCCGCTGTTTCAGGTGTTGACGCTGGGCGGTATCTTCCAGACGGCGTCGTACGCAACCTACTGGGTGTTCCTGTCGAAGGGGTTGATGCGCGAGCAGTTGGTGTATTCGTTGGTCGGTCGCATCCTGCTCATCGCCTGCATTTTTGTTGGCTCCCGCTGGGGGGCCATGGGCGTGGCGATCGGCTACTCATTCGGCCTGCTGTTGATCTGGCCGCTGTCGCTGGTCTGGATCGGCAAGATCACGGACGCACCGGTCGGTGCGTTGTTCGTCAATGCCATGCGTGCGCTGGTGGCCTACGGTATCGCCGGCGGCTGCGCTTATTACGCATCGGTCACTGTCGGTGGTCCATTGTGGCAGCAGCTGCTGGTCGGCGCCGGCGCGATGGCGCTGGTCTGTCTGCTCGCATTGGCATGGCCGGGATTCCGGCGTGACGTGGTCGCTATCGTCAATATCCGCAAGCTGCTCACGCAGGCGAAGGCGCGCCGATGA	MTAETSTMTSPTPPPRSLGSRAAGAAVTMIGQSAKMIVQFGGIVLLARLLTPYDYGLMAMVTAIVGAAEILRDFGLSAAAVQAKHVSREQRDNLFWINSGIGLMLSVVVFASAHWIADFYHEPALVTISQALAVTFLLNGMTTQYRAHLSRGLRFGQVALSDVGSQVLGLGAAVAAALAGWGYWALIVQQVVQAIVNLIIAGACARWLPRGYARQAPMRDFMSFGWNLMAAQLLGYASRNVGQVIIGWRTGPDALGLYNRAFQLLMMPLNQINAPATSVALPVLSQLQDERERYSAFLLRGQTVMVHLIFALFAFACALAMPLIVLVLGEQWREAVPLFQVLTLGGIFQTASYATYWVFLSKGLMREQLVYSLVGRILLIACIFVGSRWGAMGVAIGYSFGLLLIWPLSLVWIGKITDAPVGALFVNAMRALVAYGIAGGCAYYASVTVGGPLWQQLLVGAGAMALVCLLALAWPGFRRDVVAIVNIRKLLTQAKARR	MKKDSKSKEMIQSEKRGSTRLLMMVLSLSVLVGAITADLVNPVLPLISKDLEASKSQVSWIVSGIALVLAIGVPIYGRISDFFELRKLYIFAIMILASGSLLCAIAPNLPLLVLGRMVQGAGMSAIPVLSIIAISKVFPQGKRGGALGIIAGSIGVGTAAGPIFGGVVGQYLGWNALFWFTFLLAIMIVIGAYYALPTIKPAESVGSNKNFDFIGGLFLGLTVGLLLFGITQGETSGFSSFSSLTSLIGSVVALVGFIWRIVTAENPFVPPVLFNNKDYVNTVIIAFFSMFAYFAVLVFVPLLVVEVNGLSSGQAGMILLPGGVAVAILSPFVGRLSDRFGDKRLIITGMTLMGLSTLFLSTYASGASPLLVSVGVLGVGIAFAFTNSPANNAAVSALDADKVGVGMGIFQGALYLGAGTGAGMIGALLSARRDATEPINPLYILDAMSYSDAFLAATGAILIALIAGLGLKKRG	104.84	gnl|BL_ORD_ID|835|hsp_num:0	907			207	414	chloramphenicol; florfenicol
BGC0000800.1|Xanthan_12 # 12445 # 13647 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.598	BGC0000800.1|Xanthan_12 	12445	13647	+	Loose	660	29.261	MexS	27.17	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCGTCTCTCCCGCAGCTCCAGCTTCCGGCATTCGCCGTCCCTGCTATCTGGTCTTGTCTGCTCACGATTTCCGCACGCCACGTCGGGCTAACATCCATTTCATCACCGATCAGTTGGCTTTGCGTGGCACGACGCGTTTTTTTTCGTTGCGATACAGCAGACTCTCCCGCATGAAGGGAGATATGCGCCTGCCGCTGGATGACACCGCAAATACCGTTGTCTCGCACAACGGTGTGGACTGTTACCTGTGGCGCACGACGGTGCATCCATTCAATACACGCCGGAGCTGGCTACGTCCTGTGGAAGACGCCATGTTCCGCTGGTATGCCGCGCATCCGCCAAAGCAGTTGCTGGACTGGATGCGCGAGTCCGATGTCATCGTGTTTGAAAGCGGGATCGCAGTCGCATTCATCGAGCTTGCCAAGCGGGTCAATCCGGCTGCCAAACTGGTCTATCGCGCGTCGGACGGGCTGAGCACCATCAACGTGGCGTCTTACATCGAGCGCGAGTTCGACCGCGTGGCTCCGACGCTGGACGTCATTGCCTTGGTGTCGCCCGCGATGGCCGCAGAAGTAGCAAGCCGCGACAACGTCTTCCATGTAGGTCACGGCGTGGACCACAACCTCGATCAGCTCGGCGACCCGTCGCCGTATGCCGAAGGCATCCATGCAGTTGCGGTCGGGTCGATGCTGTTTGATCCTGAATTTTTCGTCGTTGCCAGCAAGGCCTTTCCGCAAGTGACCTTCCACGTGATCGGCTCCGGGATGGGCCGCCATCCGGGCTACGGCGACAATGTCATTGTCTATGGCGAAATGAAGCACGCGCAGACGATTGGCTATATCAAGCACGCACGTTTCGGCATTGCGCCTTACGCGTCCGAGCAGGTGCCGGTGTATCTGGCAGACAGCTCAATGAAATTGCTGCAATACGACTTTTTCGGCTTGCCGGCGGTGTGCCCGAATGCTGTGGTGGGGCCGTACAAATCGCGCTTCGGGTACACGCCAGGCAATGCCGATTCGGTGATTGCCGCCATTACCCAGGCACTGGAAGCACCGCGTGTACGTTACCGCCAGTGTCTCAACTGGTCCGACACCACCGACCGCGTGCTCGACCCACGGGCGTACCCGGAAACCCGTCTTTATCCGCACCCCCCCACCGCCGCGCCGCAGCTCTCTTCGGAGGCAGCGCTCTCACATTGA	MSVSPAAPASGIRRPCYLVLSAHDFRTPRRANIHFITDQLALRGTTRFFSLRYSRLSRMKGDMRLPLDDTANTVVSHNGVDCYLWRTTVHPFNTRRSWLRPVEDAMFRWYAAHPPKQLLDWMRESDVIVFESGIAVAFIELAKRVNPAAKLVYRASDGLSTINVASYIEREFDRVAPTLDVIALVSPAMAAEVASRDNVFHVGHGVDHNLDQLGDPSPYAEGIHAVAVGSMLFDPEFFVVASKAFPQVTFHVIGSGMGRHPGYGDNVIVYGEMKHAQTIGYIKHARFGIAPYASEQVPVYLADSSMKLLQYDFFGLPAVCPNAVVGPYKSRFGYTPGNADSVIAAITQALEAPRVRYRQCLNWSDTTDRVLDPRAYPETRLYPHPPTAAPQLSSEAALSH	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	117.99	gnl|BL_ORD_ID|1039|hsp_num:0	1041			414	678	ciprofloxacin; trimethoprim; chloramphenicol
BGC0000800.1|Xanthan_13 # 13689 # 14483 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.599	BGC0000800.1|Xanthan_13 	13689	14483	+	Loose	400	26.1794	tetB(P)	48.0	3000195	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGCCAACGCTTTACTGCAGAAATGGGTGGAACGGGCGGAACGTCGCGCATTGTTCTGGTGGCAGCCCAAAAACGGTGGCGTGAACATGGGGGATCACCTGTCGAAGGTGATCGTGTCGTGCGTGTTGGCGTTGCAGGACAAGACACTTCTGGAAAAACGCGATTTGCGCCAGAAGCTGATCGCAACCGGGTCGGTGCTGCATTTCGCCAAAGATGGCGACACCGTGTGGGGAAGCGGTATCAACGGCAAGATTCCGGCCGAGCGCAATACGTTCAGCACGCTGGACGTACGCGCGGTACGCGGTCCCAAGACCCGCGCATTTTTGCTGGAACGTGGCATCGCAGTGCCTGAGGTCTACGGAGACCCGGGATTGCTGACCCCGATGTTTTTCCCCGCCGACGCCCTCGGCCCGGTCACCAAGCGCCCGTTCGCGATCGTGCCGCACTTCAACGAGCCGGTTGAGAAGTACAGCGCCTACGCCGAGCATCTGGTGTTTCCCAACGTCAAGCCGGCCACCTTCATGAGTGCGCTGCTGGGTGCGGAATTTGTCATCAGCAGTTCGCTGCATGGCCTGATCCTGGCCGAAGCCTATGGCATCCCGGCGGTGTATCTGGACTGGGGCAACGGCGAAGACCGTTTCAAGTACGACGACTACTACCACGGCACCGGGCGCATGCAATGGCATGCCGGCCACAGCGTGGAAGAATGCATGGAACTGGGCGGCAACGGCAGTTTCGATCTTGAACGCTTGCAGGCAGGATTGCTGGCTGCGTTCCCTTACGATTTGTGGTGA	MANALLQKWVERAERRALFWWQPKNGGVNMGDHLSKVIVSCVLALQDKTLLEKRDLRQKLIATGSVLHFAKDGDTVWGSGINGKIPAERNTFSTLDVRAVRGPKTRAFLLERGIAVPEVYGDPGLLTPMFFPADALGPVTKRPFAIVPHFNEPVEKYSAYAEHLVFPNVKPATFMSALLGAEFVISSSLHGLILAEAYGIPAVYLDWGNGEDRFKYDDYYHGTGRMQWHAGHSVEECMELGGNGSFDLERLQAGLLAAFPYDLW	MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSSTISFNWNNVKVNIIDTPGHVDFISEVERSLNSLDGAILVISGVEGIQSQTRILFDTLKELNIPTIIFVNKLDRIGANFNKVFEEIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCIINDDAINVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYAREGSLYPVFCGAAAIGLGIEDLLDGICSYFPFASNDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKVKKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISAIDKEKNPELFKALTLLAEEDPLLAFAMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVEFSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKSFQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQTVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMKIASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD	40.49	gnl|BL_ORD_ID|737|hsp_num:0	804			1569	1644	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000800.1|Xanthan_14 # 14527 # 15282 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.673	BGC0000800.1|Xanthan_14 	14527	15282	+	Loose	200	26.9498	vanT gene in vanC cluster	24.0	3002970	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	GTGAGTGCAGCGACACCTGCGCAAGGGGTGGTGATTCCGCTGGGCGGCTTCCCGGTGTTGTCGACCACGCAGGAAGCCTTCGCGCTGGATCTGTTCCATGCGCTGGCCGCGCATCAGCCGCGCCGGGTGTTTTTCGCGAACACCAACTTCATCGTGCAGTGCCAGGCGCTGCGCGCGCGCATGCAGGCGCCGGCAGTGCGCATCGTCAACGATGGGATCGGCATGGATCTGGCGGCGCGCCTGATCCATGGCCGCCGGTTCGCCGGCAACCTCAACGGCACCGACCTGATTCCGTACCTTTGCCGCGAGGCCGCGCAGCCGCTCAAGTTCTTCCTGCTCGGCGGCCGCCCGGGCGTGGGCAAGACCGCCGCGGCGACCTTGACCGGAACGCTGGGCCAGCAGGTCGTGGGCATGTGCGATGGGTATGGCGAATTTGCGGCGGCGGGCGAGGGCCTGGCCGAGCGCATCAATCGCTCCGGCGCCGATGTGCTGTTGGTGGCCTTCGGCAACCCGCTGCAGGAGCGGTGGATCCTGGACCACAGCGAGGCCTTGCAGGTGCCGCTGGTGTTCGGCGTGGGCGCCTTGCTGGATTTTCTCTCCGGCACTGCCAAGCGCGCGCCCAACTGGGTGCGCCGTTTGCATATGGAATGGATGTACCGGCTGCTCAACGAGCCGCGCCGGTTGCTCAAGCGCTACAGCTGGGATCTGCTGGTGTTCTTCCGCACCTGCCTGCGTGCGGGCAAACAGCTGGCGTGA	MSAATPAQGVVIPLGGFPVLSTTQEAFALDLFHALAAHQPRRVFFANTNFIVQCQALRARMQAPAVRIVNDGIGMDLAARLIHGRRFAGNLNGTDLIPYLCREAAQPLKFFLLGGRPGVGKTAAATLTGTLGQQVVGMCDGYGEFAAAGEGLAERINRSGADVLLVAFGNPLQERWILDHSEALQVPLVFGVGALLDFLSGTAKRAPNWVRRLHMEWMYRLLNEPRRLLKRYSWDLLVFFRTCLRAGKQLA	MKNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDILITLTIFRVAVPFFFMISGYYVFAELAVANSYPSRQRVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQVLLVNGILYHLWYFPALITGSLLLTSLLIHVSFKKVFWLAAGLYLIGLGGDSWFGLIQQTPIEPFYTAVFHLLDGTRNGIFFTPLFLCLGVLVRKQSEKRSLSKTALFFLISLIGLLIESAYLHGFSIPKHDSMYLFLPVVLFFLFPLILRWHPHRTWKHPGQLSLWLYLLHPYTIAGTHFLSQKISILQNNLINYLVVLILTIGFICLFLRQKHSWFRHKQTTPVKRAVKEFSKTALLHNLQEIQRIISPKTKVMAVVKADAYGCGAKEVAPVLEQAGIDFFAVATIDEGIRLRKNAVKSPILVLGYTSPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTIDSILSIFDLPFLTISGVYSHLGSADRLNPDSMIRTQKQIACFDQILLELDQRQISYGITHLQSSYGILNYPDLNYDYVRPGILLTGSLSDTNEPTKQRVSLQPILTLKAQLITKRVVAKGEAIGYGQTAVANQETTVGVVSIGYCDGLPRSLSNQEFCLSYRGQSLPQIGLICMDMLLIDLSHCPTIPIESEIEILTDWSDTAEQVQTITNELICRIGPRVSARIK	35.96	gnl|BL_ORD_ID|4675|hsp_num:0	734			1773	2055	vancomycin
BGC0000800.1|Xanthan_16 # 15871 # 16074 # 1 # ID=1_16;partial=01;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.696	BGC0000800.1|Xanthan_16 	15871	16074	+	Loose	400	22.7126	VIM-17	34.04	3002287	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	ATGCAGCGCAGGGGGGCGGTGTGGCGGGCAGGAATCGCGTTGGTGTCGTTGTTGGCACCGATGCTGGCGTGTGCCGTCGAGGTGGCCGTACAGGCGCCGGCAGCGCCGCCAACGGTGGTCGATCTGGAAGCCATGGTGGTGCGCGGGCAGCAACCCGGCCCCGGCCTGTGGAAGGTCAGCAAGGGCGACCACGTGCTGTGGATC	MQRRGAVWRAGIALVSLLAPMLACAVEVAVQAPAAPPTVVDLEAMVVRGQQPGPGLWKVSKGDHVLWI	MFKLLSKLLVYLTASMMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQSFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGHGLPGGLDLLKHTTNVVKAHTNRSVVE	25.56	gnl|BL_ORD_ID|150|hsp_num:0	168			24	165	
